Showing results (111-120 of 271) with videos related to
Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|April 5, 2014
The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the futureR Hajhosseiny, I Sabir, K Khavandi, et al.International Journal of Cardiology|September 6, 2003
Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failureRashed Bakri, Joe Wang, Anthony S Wierzbicki, et al.Current Opinion in Cardiology|April 25, 2012
Statins and noncardiac vascular diseaseKosmas I Paraskevas, Anthony S Wierzbicki, Dimitri P MikhailidisCurrent Medical Research and Opinion|June 18, 2004
Concordance evaluation of coronary risk scores: implications for cardiovascular risk screeningTimothy M Reynolds, Patrick J Twomey, Anthony S WierzbickiInternational Journal of Clinical Practice|September 23, 1998
Profound hyponatraemia following an idiosyncratic reaction to diureticsA S Wierzbicki, S G Ball, N K SinghJournal of Clinical Pathology|January 24, 2018
Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudyTimothy M Reynolds, Clare Mewies, John Hamilton, et al.International Journal of Clinical Practice. Supplement|May 7, 2005
Ezetimibe-induced hyperlipidaemiaE Doherty, P J Lumb, G Chik, et al.International Journal of Clinical Practice|May 30, 2021
Screening for patients with Gaucher's disease using routine pathology results: PATHFINDER (ferritin, alkaline phosphatase, platelets) studyTimothy M Reynolds, Anthony S Wierzbicki, Volha Skrahina, et al.Annals of Clinical Biochemistry|November 1, 1996
Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profileA Jefferson, T M Reynolds, A Elves, et al.International Journal of Clinical Practice|June 23, 2004
Effect of moxonidine on lipid subfractions in patients with hypertensionP J Lumb, Z McMahon, G Chik, et al.Pageof 28